Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alex Yuang-chi Chang
Molecular Mechanism of Action and Potential Biomarkers of Growth Inhibition of Synergistic Combination of Afatinib and Dasatinib Against Gefitinib-Resistant Non-Small Cell Lung Cancer Cells
Oncotarget
Oncology
Related publications
Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
PLoS ONE
Multidisciplinary
Molecular Mechanisms of Action and Potential Biomarkers of Growth Inhibition of Dasatinib (BMS-354825) on Hepatocellular Carcinoma Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Inhibition of SREBP Increases Gefitinib Sensitivity in Non-Small Cell Lung Cancer Cells
Oncotarget
Oncology
ERK Inhibition Represses Gefitinib Resistance in Non-Small Cell Lung Cancer Cells
Oncotarget
Oncology
Gefitinib Radiosensitizes Non-Small Cell Lung Cancer Cells Through Inhibition of Ataxia Telangiectasia Mutated
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Synergistic Combinations of Paclitaxel and Withaferin a Against Human Non-Small Cell Lung Cancer Cells
Oncotarget
Oncology
Role of FBXW7 in the Quiescence of Gefitinib-Resistant Lung Cancer Stem Cells in EGFR-mutant Non-Small Cell Lung Cancer
Bosnian Journal of Basic Medical Sciences
Medicine
Enhancement of Epidermal Growth Factor Receptor-Degradation Pathway in Acquired Gefitinib-Resistant Human Non-Small Cell Lung Cancer Cell Lines
The Showa University Journal of Medical Sciences
Gefitinib for the Treatment of Non-Small-Cell Lung Cancer
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
